B0F logo

Paxman AB (publ)DB:B0F Stock Report

Market Cap €141.8m
Share Price
€6.06
My Fair Value
€9.66
37.2% undervalued intrinsic discount
1Y25.5%
7D-1.9%
Portfolio Value
View

Paxman AB (publ)

DB:B0F Stock Report

Market Cap: €141.8m

Paxman (B0F) Stock Overview

Develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. More details

B0F fundamental analysis
Snowflake Score
Valuation2/6
Future Growth6/6
Past Performance2/6
Financial Health5/6
Dividends0/6

B0F Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Paxman AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for Paxman
Historical stock prices
Current Share PriceSEK 6.06
52 Week HighSEK 7.58
52 Week LowSEK 4.67
Beta0.29
1 Month Change-9.28%
3 Month Change-18.77%
1 Year Change25.47%
3 Year Change61.60%
5 Year Changen/a
Change since IPO20.84%

Recent News & Updates

Recent updates

Shareholder Returns

B0FDE Medical EquipmentDE Market
7D-1.9%5.3%2.7%
1Y25.5%-9.3%14.6%

Return vs Industry: B0F exceeded the German Medical Equipment industry which returned -9.3% over the past year.

Return vs Market: B0F exceeded the German Market which returned 14.6% over the past year.

Price Volatility

Is B0F's price volatile compared to industry and market?
B0F volatility
B0F Average Weekly Movement6.4%
Medical Equipment Industry Average Movement5.2%
Market Average Movement4.9%
10% most volatile stocks in DE Market12.3%
10% least volatile stocks in DE Market2.5%

Stable Share Price: B0F has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: B0F's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1996140Richard Paxmanpaxmanscalpcooling.com

Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to develop a wearable medical cooling device; and the National University Hospital of Singapore for the development of a cooling and compression system.

Paxman AB (publ) Fundamentals Summary

How do Paxman's earnings and revenue compare to its market cap?
B0F fundamental statistics
Market cap€141.82m
Earnings (TTM)€786.18k
Revenue (TTM)€25.81m
180.4x
P/E Ratio
5.5x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
B0F income statement (TTM)
RevenueSEK 283.78m
Cost of RevenueSEK 97.39m
Gross ProfitSEK 186.38m
Other ExpensesSEK 177.74m
EarningsSEK 8.64m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

Nov 14, 2025

Earnings per share (EPS)0.37
Gross Margin65.68%
Net Profit Margin3.05%
Debt/Equity Ratio4.2%

How did B0F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/05 14:29
End of Day Share Price 2025/10/03 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Paxman AB (publ) is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ludvig SvenssonDNB Carnegie Commissioned Research
Mats HyttingeRedeye